On October 29, 2020 Alkermes plc (Nasdaq: ALKS) reported that the conference call to discuss the company’s third quarter financial results is rescheduled due to technical difficulties impacting the conference call provider (Press release, Alkermes, OCT 29, 2020, View Source [SID1234569443]). The company now plans to host the conference call and webcast presentation at 10:30 a.m. ET (2:30 p.m. GMT) on Thursday, Oct. 29, 2020.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes’ website at www.alkermes.com. The conference call may be accessed by dialing +1 844 602 0380 for U.S. callers and +1 862 298 0970 for international callers. The conference ID is 81030951.

A replay of the conference call will be available through Thursday Nov. 5, 2020, and may be accessed by visiting Alkermes’ website.